Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

545
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
545

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding the Malignant Potential of Hydatidiform Moles through Fibroblast and LAIR2 Signatures.

Cancer communications (London, England)·2026
Same author

Integrating ultrasound-CT-MR for preoperative multi-task prediction in ovarian cancer: achieving diagnostic parity with multidisciplinary team consensus.

NPJ digital medicine·2026
Same author

Enhanced gastrointestinal stability and therapeutic efficacy of biofilm self-coated Bacillus amyloliquefaciens C-1 probiotic in ulcerative colitis.

NPJ science of food·2026
Same author

Sonocavitation-Induced Mitochondrial Dysfunction via ROS-Mediated Apoptosis for Paclitaxel-Resistant Ovarian Cancer Therapy.

Ultrasound in medicine & biology·2026
Same author

Low Power Consumption Silica Thermo-Optic Switch Based on Polymer Cladding.

Polymers·2025
Same author

Dissecting trophoblastic heterogeneity in abnormal pregnancy: Insights from comparative analysis of twin-pregnancy with hydatidiform mole and coexisting live fetus.

Genes & diseases·2025

Related Experiment Video

Updated: Apr 19, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.4K

Methotrexate management for placenta accreta: a prospective study.

Kaiqing Lin1, Jiale Qin, Kaihong Xu

  • 1Department of Gynecology, Women's Hospital, Zhejiang University School of Medicine, 1 Xueshi Road, Hangzhou, 310006, Zhejiang, People's Republic of China.

Archives of Gynecology and Obstetrics
|December 16, 2014
PubMed
Summary
This summary is machine-generated.

Methotrexate (MTX) management offers a conservative approach for stable placenta accreta patients. Successful treatment involves significant decreases in beta-hCG and placental vascular indices, confirmed by ultrasound.

More Related Videos

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

10.2K
Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

4.0K

Related Experiment Videos

Last Updated: Apr 19, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.4K
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

10.2K
Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

4.0K

Area of Science:

  • Reproductive Medicine
  • Gynecologic Oncology

Background:

  • Placenta accreta poses significant risks during pregnancy.
  • Conservative management strategies are crucial for stable patients.

Purpose of the Study:

  • To evaluate the efficacy of methotrexate (MTX) in managing placenta accreta.
  • To identify predictors of successful MTX treatment.

Main Methods:

  • Prospective study of 24 stable placenta accreta patients treated with MTX.
  • Monitoring of beta-hCG levels and placental vascular indices.
  • Comparison between successful and failed treatment groups.

Main Results:

  • Spontaneous expulsion occurred in 33.3%, D&C in 45.8%.
  • Residual placental absorption averaged 5.7 months.
  • Faster decline in beta-hCG and vascular indices in successful MTX cases (P < 0.05).
  • Failed cases showed persistent or elevated vascular indices despite decreased hCG.

Conclusions:

  • MTX is a viable conservative option for stable placenta accreta, indicated by declining beta-hCG and vascular indices.
  • 3D power Doppler ultrasound is recommended for monitoring treatment response.